Article

Revealing heterogeneity of brain imaging phenotypes in Alzheimer’s disease based on unsupervised clustering of blood marker profiles

2018-06-05

Abstract excerpt

Alzheimer’s disease (AD) affects millions of people and is a major rising problem in health care worldwide. Recent research suggests that AD could have different subtypes, presenting differences in how the disease develops. Characterizing those subtypes could be key to deepen the understanding of this complex disease. In this paper, we used a multivariate, non-supervised clustering method over blood-based markers...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: a1c39332-ed6d-593d-9f7c-30e3398f7b5e
DOI: 10.1101/339614

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Revealing heterogeneity of brain imaging phenotypes in Alzheimer’s disease based on unsupervised clustering of blood marker profilesDOI 10.1101/339614Read

Alzheimer’s subtypes A supervised, unsupervised, multimodal, multilayered embedded recursive (SUMMER) AI studySemantic proximity Read

Multivariate protein signatures of pre-clinical Alzheimer's disease in the Alzheimer's disease neuroimaging initiative (ADNI) plasma proteome dataset.Semantic proximity Read

Integrative analyses of neuroimaging, clinical, and multi-omics data identified meaningful Alzheimer’s disease progression subtypesSemantic proximity Read

AI System Using Unsupervised Learning to Discover Novel Subtypes in Alzheimer’s DiseaseSemantic proximity Read

Identify Alzheimer’s disease subtypes and markers from multi-omic data of human brain and blood with a subspace merging algorithmSemantic proximity Read

Multimodal and longitudinal characterization of distinct tau and atrophy clusters in Alzheimer’s disease spectrumSemantic proximity Read

Genetic, Clinical Underpinnings of Brain Change Along Two Neuroanatomical Dimensions of Clinically-defined Alzheimer’s DiseaseSemantic proximity Read

Genetic, structural and functional imaging biomarkers for early detection of conversion from MCI to AD.Semantic proximity Read

Deep learning-driven risk-based subtyping of cognitively impaired individualsSemantic proximity Read

Plasma proteomics reveals continuous molecular heterogeneity rather than discrete subtypes in Alzheimer’s diseaseSemantic proximity Read

Towards a multimodal neuroimaging-based risk score for mild cognitive impairment by combining clinical studies with a large (N>37000) population-based studySemantic proximity Read

Multimodal Integration of Alzheimer's Plasma Biomarkers, MRI, and Genetic Risk for Individual Prediction of Cerebral Amyloid BurdenSemantic proximity Read